載入...
Delivery of oligonucleotide‐based therapeutics: challenges and opportunities
Nucleic acid‐based therapeutics that regulate gene expression have been developed towards clinical use at a steady pace for several decades, but in recent years the field has been accelerating. To date, there are 11 marketed products based on antisense oligonucleotides, aptamers and small interferin...
Na minha lista:
| 發表在: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8033518/ https://ncbi.nlm.nih.gov/pubmed/33821570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202013243 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|